Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunity
Riccardo Guidi,Christopher Wedeles,Daqi Xu,Krzysztof Kolmus,Sarah E Headland,Grace Teng,Joseph Guillory,Yi Jimmy Zeng,Tommy K Cheung,Subhra Chaudhuri,Zora Modrusan,Yuxin Liang,Stuart Horswell,Benjamin Haley,Sascha Rutz,Christopher Rose,Yvonne Franke,Donald S Kirkpatrick,Jason A Hackney,Mark S Wilson
DOI: https://doi.org/10.1016/j.celrep.2023.113515
2023-12-26
Abstract:Argonaute (AGO) proteins execute microRNA (miRNA)-mediated gene silencing. However, it is unclear whether all 4 mammalian AGO proteins (AGO1, AGO2, AGO3, and AGO4) are required for miRNA activity. We generate Ago1, Ago3, and Ago4-deficient mice (Ago134Δ) and find AGO1/3/4 to be redundant for miRNA biogenesis, homeostasis, or function, a role that is carried out by AGO2. Instead, AGO1/3/4 regulate the expansion of type 2 immunity via precursor mRNA splicing in CD4+ T helper (Th) lymphocytes. Gain- and loss-of-function experiments demonstrate that nuclear AGO3 interacts directly with SF3B3, a component of the U2 spliceosome complex, to aid global mRNA splicing, and in particular the isoforms of the gene Nisch, resulting in a dysregulated Nisch isoform ratio. This work uncouples AGO1, AGO3, and AGO4 from miRNA-mediated RNA interference, identifies an AGO3:SF3B3 complex in the nucleus, and reveals a mechanism by which AGO proteins regulate inflammatory diseases.